Delivery Order SPE2DB22D3501-SPE2DB25FXK69
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,085.34 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Isotretinoin 30 mg capsules (30-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 27, 2025. The contract will be performed at the awardee's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,226.11 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Isotretinoin 40 mg capsules (30-count packaging). This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 2, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,976.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of June 10, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a $5,344.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). The contract, which is classified as a non-set-aside award, is scheduled for completion by October 20, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,522.91 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Isotretinoin 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,584.30 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 20 mg capsules (30-count units) with a ceiling value of $1,225.40. This is a firm fixed-price delivery order with no set-aside designation, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,763.80 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This contract is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location and is a major pharmaceutical distributor specializing in medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11.4K to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK69Delivery Order
The Defense Logistics Agency awarded a $1,538.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Isotretinoin 40 mg capsules (30-count packaging). This is a non-set-aside contract with an ultimate completion date of September 19, 2025, performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle with DLA. This prime contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to fulfill defense health requirements through competitive awards, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/18/25 |